Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Basil Rapoport

Showing results (11-20 of 105) with videos related to

Pageof 11
Sort By:
Clinical Endocrinology|June 24, 2004
Thyroid stimulating monoclonal antibodies: overcoming the road blocks and the way forwardSandra M McLachlan, Basil Rapoport
Endocrine Reviews|July 26, 2016
Withdrawn: TSH Receptor Cleavage Into Subunits and Shedding of the A-Subunit; A Molecular and Clinical PerspectiveBasil Rapoport, Sandra M McLachlan
Endocrine Reviews|January 23, 2016
TSH Receptor Cleavage Into Subunits and Shedding of the A-Subunit; A Molecular and Clinical PerspectiveBasil Rapoport, Sandra M McLachlan
Thyroid : Official Journal of the American Thyroid Association|April 6, 2018
A Role for Satb1 in Thyroid Autoimmunity?Sandra M McLachlan, Basil Rapoport
Thyroid : Official Journal of the American Thyroid Association|October 3, 2012
Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versaSandra M McLachlan, Basil Rapoport
Thyroid : Official Journal of the American Thyroid Association|July 18, 2008
Whither TSH receptor blocking antibodies in the treatment of Graves' disease?Basil Rapoport, Sandra M McLachlan
Thyroid : Official Journal of the American Thyroid Association|September 8, 2007
The thyrotropin receptor in Graves' diseaseBasil Rapoport, Sandra M McLachlan
The Journal of Clinical Endocrinology and Metabolism|September 12, 2014
Graves' hyperthyroidism is antibody-mediated but is predominantly a Th1-type cytokine diseaseBasil Rapoport, Sandra M McLachlan
Endocrine|September 28, 2019
A transgenic mouse that spontaneously develops pathogenic TSH receptor antibodies will facilitate study of antigen-specific immunotherapy for human Graves' diseaseSandra M McLachlan, Basil Rapoport
Endocrine Reviews|April 14, 2005
Insight into Graves' hyperthyroidism from animal modelsSandra M McLachlan, Yuji Nagayama, Basil Rapoport
Pageof 11

Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
Clinical Endocrinology|June 24, 2004
Thyroid stimulating monoclonal antibodies: overcoming the road blocks and the way forwardSandra M McLachlan, Basil Rapoport
Endocrine Reviews|July 26, 2016
Withdrawn: TSH Receptor Cleavage Into Subunits and Shedding of the A-Subunit; A Molecular and Clinical PerspectiveBasil Rapoport, Sandra M McLachlan
Endocrine Reviews|January 23, 2016
TSH Receptor Cleavage Into Subunits and Shedding of the A-Subunit; A Molecular and Clinical PerspectiveBasil Rapoport, Sandra M McLachlan
Thyroid : Official Journal of the American Thyroid Association|April 6, 2018
A Role for Satb1 in Thyroid Autoimmunity?Sandra M McLachlan, Basil Rapoport
Thyroid : Official Journal of the American Thyroid Association|October 3, 2012
Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versaSandra M McLachlan, Basil Rapoport
Thyroid : Official Journal of the American Thyroid Association|July 18, 2008
Whither TSH receptor blocking antibodies in the treatment of Graves' disease?Basil Rapoport, Sandra M McLachlan
Thyroid : Official Journal of the American Thyroid Association|September 8, 2007
The thyrotropin receptor in Graves' diseaseBasil Rapoport, Sandra M McLachlan
The Journal of Clinical Endocrinology and Metabolism|September 12, 2014
Graves' hyperthyroidism is antibody-mediated but is predominantly a Th1-type cytokine diseaseBasil Rapoport, Sandra M McLachlan
Endocrine|September 28, 2019
A transgenic mouse that spontaneously develops pathogenic TSH receptor antibodies will facilitate study of antigen-specific immunotherapy for human Graves' diseaseSandra M McLachlan, Basil Rapoport
Endocrine Reviews|April 14, 2005
Insight into Graves' hyperthyroidism from animal modelsSandra M McLachlan, Yuji Nagayama, Basil Rapoport
Pageof 11